I think the Resulin story from allegedly being found as a byproduct of some Japanese study.
There was something Allegedly about an FDA employee and a white paper.
It is not unknown to down play problems when so much money is involved.
When you mess with the liver it should require special care.
There is a lot of pressure on many people to get to market and reap huge profits And to exploit the
patent laws to secure a market.
When it is a matter of money I have seen a lot of bending of ethical conduct by those that verbally
live by the term.
I used to hear the term "intrinsic respectively. Frequently. it used to apply but the buck has
altered the game today. . Lived too long and seen too many cases. Of course L an old and senile.
Still read all I can find about diabetic drugs. Guy
PS What was that was the name of the FDA employee that left and took a position in a drug company?.
When did that happen?